Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Dominique, Bédard"'
Autor:
Imane Frouni, Dominique Bédard, Élodie Bourgeois-Cayer, Adjia Hamadjida, Fleur Gaudette, Francis Beaudry, Philippe Huot
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 396:1053-1060
Autor:
Min Su Kang, Adjia Hamadjida, Dominique Bédard, Stephen G. Nuara, Jim C. Gourdon, Stephen Frey, Arturo Aliaga, Karen Ross, Robert Hopewell, Hussein Bdair, Axel Mathieu, Christine Lucas Tardif, Jean-Paul Soucy, Gassan Massarweh, Pedro Rosa-Neto, Philippe Huot
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology.
Autor:
Cynthia Kwan, Catherine Lévesque, Dominique Bédard, Imane Frouni, Jemal M Yesuf, Adjia Hamadjida, Daniel Lévesque, Paul BS Clarke, Philippe Huot
Publikováno v:
Neuroscience Research. 177:135-144
Autor:
Jim C. Gourdon, Robert Hopewell, Stephen G. Nuara, Christine L. Tardif, Adjia Hamadjida, Min Su Kang, Cynthia Kwan, Dominique Bédard, Philippe Huot, Jean-Paul Soucy, Hussein Bdair, Karen Ross, Gassan Massarweh, Wen Luo, Thomas M. Durcan, Irina Shlaifer, Stephen Frey, Edward A. Fon, Pedro Rosa-Neto, Esther del Cid Pellitero
Publikováno v:
Neuroscience. 480:143-154
The common marmoset has emerged as a popular model in neuroscience research, in part due to its reproductive efficiency, genetic and neuroanatomical similarities to humans and the successful generation of transgenic lines. Stereotaxic procedures in m
Autor:
Imane, Frouni, Cynthia, Kwan, Sébastien, Belliveau, Adjia, Hamadjida, Dominique, Bédard, Stephen G, Nuara, Jim C, Gourdon, Philippe, Huot
Publikováno v:
European journal of pharmacology. 939
In previous experiments, we have discovered that positive allosteric modulation of metabotropic glutamate 2 (mGlu
Autor:
Adjia Hamadjida, Imane Frouni, Sébastien Belliveau, Woojin Kang, Dominique Bédard, Jim C. Gourdon, Stephen G. Nuara, Cynthia Kwan, Philippe Huot
Publikováno v:
Journal of Neural Transmission. 128:73-81
Advanced Parkinson’s disease (PD) is often complicated by the occurrence of dyskinesia, motor fluctuations and psychosis. To this day, few treatment options are available for each of these phenomena, and they are at times not effective or elicit ad
Publikováno v:
Biomedical chromatography : BMCREFERENCES. 36(9)
A rapid, selective and sensitive method was developed and validated for the determination of LY-404,039 concentration in rat plasma using a butylation derivatization step to improve chromatographic characteristics and enhance signal intensity. The me
Autor:
Dominique Bédard, Imane Frouni, Adjia Hamadjida, Jim C. Gourdon, Cynthia Kwan, Philippe Huot, Stephen G. Nuara
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 393:2157-2164
Whereas monoamine oxidase (MAO) type B inhibitors are used as adjunct to L-3,4-dihydroxyphenylalanine (L-DOPA) in the treatment of Parkinson’s disease (PD), the enzyme MAO type A (MAO-A) also participates in the metabolism of dopamine in the human
Autor:
Cynthia Kwan, Adjia Hamadjida, Imane Frouni, Francis Beaudry, Dominique Bédard, Fleur Gaudette, Philippe Huot
Publikováno v:
Canadian Journal of Physiology and Pharmacology. 98:431-440
The availability of agonists and antagonists to modulate the activity of the 5-hydroxytryptamine (5-HT) type 3 (5-HT3) receptor has renewed interest in its role as a therapeutic target. Ondansetron is a highly selective 5-HT3 receptor antagonist that
Autor:
Adjia Hamadjida, Jim C. Gourdon, Stephen G. Nuara, Cynthia Kwan, Imane Frouni, Philippe Huot, Dominique Bédard
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 393:2139-2144
Monoamine oxidase (MAO) type B (MAO-B) inhibition was shown to confer anti-parkinsonian benefit as monotherapy and adjunct to l-3,4-dihydroxyphenylalanine (l-DOPA) in clinical trials. Here, we explore the anti-parkinsonian effect of MAO type A (MAO-A